Effect of laser immunotherapy and surgery on the treatment of mouse mammary tumors

Laser immunotherapy using laser photothermal therapy and immunological stimulation could achieve tumor-specific immune responses, as indicated by our previous pre-clinical and preliminary clinical studies. To further study the effect of laser immunotherapy, we conducted an investigation combining laser immunotherapy and surgery. After laser immunotherapy, treated tumors were surgically removed at different time points. The survival rates of treated mice were compared among different groups. Furthermore, the cured mice were rechallenged to test the immunity induced by laser immunotherapy. Our results showed that the mice treated with surgical removal one week after laser immunotherapy had the highest survival rate (77%). When the tumors were removed immediately after laser immunotherapy treatment, the survival rate was 57%. Most cured mice withstood tumor rechallenges, indicating an induction of tumor immunity by laser immunotherapy. The differentiations between different surgery groups indicate that the treated tumors have contributed to the immunological responses of the hosts.

[1]  R. Nordquist,et al.  Tumour Cell Damage and Leucocyte Infiltration after Laser Immunotherapy Treatment , 2000, Lasers in Medical Science.

[2]  Charles Wiggins,et al.  Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. , 2007, Cancer.

[3]  K. Bartels,et al.  Chromophore-enhanced in vivo tumor cell destruction using an 808-nm diode laser. , 1995, Cancer letters.

[4]  Michael R Hamblin,et al.  Photodynamic therapy and anti-tumour immunity , 2006, Nature Reviews Cancer.

[5]  K. Bartels,et al.  Photothermal effects on murine mammary tumors using indocyanine green and an 808-nm diode laser: an in vivo efficacy study. , 1996, Cancer letters.

[6]  M. Palladino,et al.  Immunity to carcinogen-induced transplantable fibrosarcoma in B2/B2 chickens. V. Relationship to tumor cell-specific delayed hypersensitivity and serum antibody. , 1982, Cellular immunology.

[7]  C. Melief,et al.  Cancer immunology. , 2011, Current opinion in immunology.

[8]  P. Kalinski,et al.  Dendritic cell-based therapeutic cancer vaccines: what we have and what we need. , 2009, Future oncology.

[9]  R. Nordquist,et al.  In situ photoimmunotherapy: a tumour‐directed treatment for melanoma , 2006, British Journal of Dermatology.

[10]  R. Nordquist,et al.  Laser-photosensitizer assisted immunotherapy: a novel modality for cancer treatment. , 1997, Cancer letters.

[11]  H J Rapp,et al.  MECHANISMS OF IMMUNOLOGICAL ERADICATION OF A SYNGENEIC GUINEA PIG TUMOR: II. EFFECT OF METHOTREXATE TREATMENT AND T CELL DEPLETION OF THE RECIPIENT ON ADOPTIVE IMMUNITY , 1983, Transplantation.

[12]  Hong Liu,et al.  Effect of different components of laser immunotherapy in treatment of metastatic tumors in rats. , 2002, Cancer research.

[13]  Antoni Ribas,et al.  Targeted Therapies to Improve Tumor Immunotherapy , 2008, Clinical Cancer Research.

[14]  R. Nordquist,et al.  Antitumor immunity induced by laser immunotherapy and its adoptive transfer. , 2001, Cancer research.

[15]  G L Bartlett,et al.  Systemic adoptive transfer of immunity to 13762A rat mammary adenocarcinoma. , 1981, Cancer research.

[16]  R J North,et al.  Radiosensitive barrier to T-cell-mediated adoptive immunotherapy of established tumors. , 1990, Cancer research.

[17]  K. Bartels,et al.  Chromophore-enhanced laser-tumor tissue photothermal interaction using an 808-nm diode laser. , 1995, Cancer letters.

[18]  L. M. Slater,et al.  Development of cyclosporin A mediated immunity in L1210 leukaemia. , 1991, British Journal of Cancer.

[19]  Keyur Mehta,et al.  Hyperthermia on immune regulation: a temperature's story. , 2008, Cancer letters.

[20]  R. North,et al.  The therapeutic significance of concomitant antitumor immunity , 2004, Cancer Immunology, Immunotherapy.

[21]  Wei R. Chen,et al.  Long‐term tumor resistance induced by laser photo‐immunotherapy , 1999, International journal of cancer.

[22]  Hong Liu,et al.  Induced antitumor immunity against DMBA‐4 metastatic mammary tumors in rats using laser immunotherapy , 2003, International journal of cancer.

[23]  Wei R Chen,et al.  Laser immunotherapy , 2003, Molecular biotechnology.

[24]  R J North,et al.  Gamma-irradiation facilitates the expression of adoptive immunity against established tumors by eliminating suppressor T cells. , 1984, Cancer immunology, immunotherapy : CII.

[25]  Circe Mesa,et al.  Challenges facing adjuvants for cancer immunotherapy , 2004, Immunology and cell biology.

[26]  E A Wiebke,et al.  Antitumor activity and immunotherapeutic properties of Flt3-ligand in a murine breast cancer model. , 1997, Cancer research.